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http://dx.doi.org/10.1016/j.jprot.2013.06.010A B S T R A C TAvailable online 19 June 2013 Background: Statistical process control is a well-established and respected method which
provides a general purpose, and consistent framework for monitoring and improving the
quality of a process. It is routinely used in many industries where the quality of final
products is critical and is often required in clinical diagnostic laboratories [1,2]. To date, the
methodology has been little utilised in research proteomics. It has been shown to be
capable of delivering quantitative QC procedures for qualitative clinical assays[3] making it
an ideal methodology to apply to this area of biological research.
Objective: To introduce statistical process control as an objective strategy for quality control
and show how it could be used to benefit proteomics researchers and enhance the quality of
the results they generate.
Results: We demonstrate that rules which provide basic quality control are easy to derive
and implement and could have a major impact on data quality for many studies.
Conclusions: Statistical process control is a powerful tool for investigating and improving
proteomics research work-flows. The process of characterising measurement systems and
defining control rules forces the exploration of key questions that can lead to significant
improvements in performance.
Biological significance
This work asserts that QC is essential to proteomics discovery experiments. Every experimenter
must know the current capabilities of their measurement system and have an objective means
for tracking and ensuring that performance. Proteomic analysis work-flows are complicated and
multi-variate. QC is critical for clinical chemistry measurements and huge strides have been
made in ensuring the quality and validity of results in clinical biochemistry labs. This work
introduces some of these QC concepts and works to bridge their use from single analyte QC to
applications in multi-analyte systems.
This article is part of a Special Issue entitled: Standardization andQuality Control in Proteomics.
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1.1. QC is ill defined and scenario dependent
In general, there is nouniversal, practical definitionof quality. As
technology improves, what was once the pinnacle of perfor-
mance can seem imprecise and insufficient in a new context.
Even in the restricted scenario of a proteomics research lab there
is no single definition as to what is a ‘high quality experiment’.
It depends on what the researcher is attempting to achieve.
The very first stage of implementing a quality control
work-flow is to work out ‘What measurable definition of
quality will deliver the goals of our research programme?’.
Consider the following two scenarios; choose to measure
the abundance of an analyte in ten biological samples to an
accuracy of six decimal places at a cost of £100 per sample, or
measure the same analyte in one hundred biological samples to
three decimal places at a cost of £10 per sample. By design, both
experiments effectively ‘cost’ the same but which is of higher
‘quality’? In terms of the accuracy of measurement, it is the
first. Butwhat if ten samples donot provide sufficient statistical
power to reliably detect the change in analyte abundance that
is occurring? The experiment is then of low quality in terms of
its potential to deliver a meaningful result at all.
It is possible to partially answer ‘What does quality mean
for this research programme?’ by asking the following more
specific questions;
• What is the current technical performance of the systems
employed?
• Is this the best performance that can be achieved?
• How do I ensure performance is maintained at these
defined levels during measurement of the experimental
variables?
The impact of variance within the measurement system
on measurements obtained from the experimental samples is
one of the key aspects that need to be understood in order
to design high-quality experiments and generate meaningful
results. It is therefore necessary to characterise and track the
performance of the measurement system.
This paper will focus on practical statistical process control
(SPC) work-flows for answering these three questions, with a
worked example using a freely available data set.
1.2. System characterisation — what is the current
technical performance of the systems employed?
Even themost complex system can be practically characterised
by treating it as a ‘black box’. A known input is introduced and
the corresponding output measured. It is assumed that if the
system is repeatedly given the same input, any deviation froma
constant value noted within the outputs must logically have
been introduced by some internal factor within the ‘black
box’ process. If this system is to be used to reliably perform
measurements then a requirement would be that, over a
reasonable number of repeats of the same input, the majority
of outputs are centred on a constant value with predictably
distributed errors around it. If these assumptions are correct, itis relatively easy to set rules which determine, for subsequent
measurements, if the black box is ‘in control’ i.e. behaving aswe
would expect, or ‘out of control’ i.e. producing an output thatwe
believe to be unlikely given the input and the characterisation
of the system previously performed.
The simplest form of system characterisation involves
measuring the same thing, the same way, a number of times.
This simple definition has some significant implications
when considering multiple analyte proteomic measurement
systems. For example, it assumes that for an identical input
sample the system can be reasonably expected to produce the
same answer for every analyte on subsequent runs (subject
only to noise variation inherent within the system).
Initially, system characterisation is an exploratory process.
How many sample replicates are required is system depen-
dent. This is a very common analysis scenario and there are
data visualisation tools and techniques available that assist
in this process. Several of these will be used in this paper to
explore the properties of a ‘real world’ data set.
1.3. Process improvement — is this the best performance
that can be achieved?
In most cases, system characterisation will lead to the
exploration of factors that impact upon data measurement.
For example, changing reagent batch may be found to shift
the operation point of the system. If down-stream processes
do not compensate for this it will have an impact on the
overall variance of the system and may also introduce
inter-batch bias to measurements. In the initial stages of
implementing a QC work-flow it can be highly beneficial to
explore such factors and look at mechanisms to mitigate
them. The variance in a set of measurements has a direct
impact on the number of samples a study requires to have
sufficient statistical power to detect significant effects, if they
are present.
1.4. Ongoing QC— how do I ensure continuing performance
at these defined levels during the measurement of the
experimental variables?
Once time and effort has been spent characterising a system,
subsequent changes in its performance must be detected.
Unnoticed drift can make the difference between a study
drawing strong conclusions, not drawing any conclusions at
all or even mis-reporting a technical issue as a true biological
effect. Plans and procedures should be in place to consistently
and objectively manage such issues.
Factors within the process can change at any time and in
subtle ways. It is important to detect change quickly so it can
be investigated and its impact assessed and mitigated. Initial
system characterisation can only report on effects present at
that time and repeat characterisation may be required at
regular intervals if there is a suggestion that parameters may
have changed — this is frequently known as ‘re-calibration’.
1.5. Statistical process control in manufacturing
Historically, almost all man-made objects were custom pieces
made by individual craftsmen of varying skill. As technology
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nents became progressively common. For such strategies to
succeed, it is necessary to manufacture components accord-
ing to certain common criteria, such as size and composition
to ensure they fit together and function as desired. Failure
to do this produces ‘waste’ in terms of items which do not
meet the grade and time spent assessing them. This led to
the concept of ‘acceptable limits’ or tolerances at the point
of manufacture of the components. The advantage of this
strategy is two-fold as it allows component manufacture to be
optimised to ‘sufficient’ measurable levels, and it also means
that the final complex object need not be completely assembled
in order to find out a component is defective.
The most efficient strategy for any complex assembly
is to detect and fail bad components as fast as possible.
This is easy to understand considering complex and valuable
final assemblies; you really don't want to build a whole car
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Fig. 1 – A simulation of 5000measures with ‘normally distributed
observations are shown as black dots. The green line shows the c
the calculated ±2 sd limits. The red lines denote the calculated ±3
a) The observations in the order that they were generated. b) The h
reordering of the points that has no impact on themean, sd or dens
impact on themean, sd or density distribution.The cost of failing late i.e. having to strip the engine down to
replace the defective gasket, will be substantially more than
the cost of the part itself. Similarly, in proteomics, despite the
fact that the cost of samples and processing them may be
high, the cost of inaccurate or false conclusions being used in
efforts to translate results into the clinic or being used as the
basis for follow on research can have huge cost implications.
Statistical process control (SPC) is a production and process
optimisation strategy, utilising a set of tools and techniques
which provide a framework for supporting the requirements
outlined in the previous sections. It has been in common use
for decades and has repeatedly proven to have a potentially
major, impact on the quality and performance of a process.
Simply performing statistics on measures of a process and
acting on them is not however ‘statistical process control’.
Fig. 1 shows the distinction quite clearly. Panel 1a shows 5000
randomly generated points (simulated from a normal dis-
tribution with a mean of 0 and sd of 1). Panel 1b shows thec
d
’ error variation (generated usingmean = 0, sd = 1). Individual
alculatedmean of the points shown. The orange lines denote
sd limits. All of the panels refer to the same set of 5000 points.
istogram and estimated density for the generated points. c) A
ity distribution. d) Another reordering of the points that has no
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to be normal. Panels 1c and 1d show other sets of 5000 points
that produce identical distribution functions to the one in
panel 1b. Panels 1c and 1d were simply created by re-ordering
the points in panel 1a so, by definition, the distributions are
mathematically identical. Generally, people look at panel 1a
and think the points are ordered randomly, but feel that
the data shown in panels 1c and 1d is subject to some form
of assignable process as there are clear patterns. As far as
standard distributional statistics is concerned, these data sets
are identical; nothing in the mean and variance calculations
would raise any concerns. In pure probability terms the
ordering of points shown in panels 1a, 1c and 1d are also
identical — the exact sequences of points are equally likely to
have occurred at random.
Shewhart [4] realised that, in terms of process control
optimisation, distributional statistics were not sufficient in
driving improvements. All that matters in improving a process
is that there is an assignable cause to the variation observed
and whether it can be practically eliminated. He takes a
pragmatic standpoint and separates variation into ‘chance
causes’ and ‘special causes’. The main difference between the
two is that ‘special causes’ have an assignable cause that can be
investigated and potentially improved if the costs and benefits
warrant it. ‘Chance causes’ are simply random variations
inherent in the process that are not assignable to a specific
cause. Simplistically ‘chance causes’ are totally random in
nature and ‘special causes’ are expected to have some form of
structure over a finite time range.
Considering Fig. 1a once more, it is evident that the
distribution of points with time has no visible pattern. We
would be hard pressed to find some form of assignable cause,
even if it exists. In contrast, Panels 1c and 1d appear to have
clear patterns that lead us to believe there may be some form
of ongoing process we can identify and isolate, with the intent
of mitigating. Only by considering the ordering of the points
do we have a way forward in process improvement.
It may be that the point ordering shown in panels 1a, 1c
and 1d have equal probability of occurring, but given our
experience of the world, panels 1c and 1d have a far higher
probability of having an assignable cause. This is a key point
in the SPC approach. It is impossible to say if the output of a
process is random or not given a finite sample of points —
which means that there is no analytical definition of whether
a process is subject to only ‘chance causes’ of variation.
A practical solution is to look for ‘tell tale’ signs that variation
is from assignable causes and investigate these as they occur.
If there is no evidence of assignable cause variation then
the process may be considered ‘in control’ and its output can
be trusted. A process with evident signs of assignable cause
variation may be considered to be ‘out of control’. This has
major implications when the process under consideration is a
measurement system, such as a laboratory test or proteomics
multiple analyte assay. If there is assignable cause variation in
the measurement, then one of the base assumptions of many
statistical tests is actually violated, potentially rendering their
conclusions invalid. Considering panel 1c again it is possible
to imagine a situation where ill-advised batching of samples
(e.g. 2500 cases followed by 2500 controls) could lead to an
apparently significant between-group difference where no truedifference exists. Shewart, in his decades of consulting and
research, reports he never found a process that did not have
some form of assignable cause variationwhen characterisation
was performed with the intent of bringing it into ‘control’ [4].
SPC can therefore be defined simply. SPC involvesmeasuring
some aspect of a process and analysing these measurements
in a way that allows the elucidation of ‘assignable cause’
variation and as such assists in its identification and remedy.
This statement implies that some form of skilled individual or
team is critical in that personnel must be able to interpret,
diagnose and act upon what they learn about a process via
continualmonitoring and improvement. A second implication is
that this never ends; a system cannot be characterised once and
the assumption thenmade that all subsequent outputswill be of
high quality for ever after.
Fig. 1 has already introduced one of the most powerful
tools employed in SPC, the control chart. In its simplest form
this is an ordered series of measurements from a process. The
panels have statistical limits placed on them (i.e. the lines
showing 2 and 3 standard deviations from the mean). If the
assumption is made that the output shown in panels 1c
and 1d is the result of assignable causes, then it is possible to
explore ‘rules’ which can be used to objectively discriminate
the type of output in panel 1a from that in panels 1c and 1d. It
may be that, although visually the difference is very striking,
it is actually non-trivial to derive a metric that works in a
generic sense (as this would require the ability to definitively
tell random from non-random). A property of random
sequences is that individual values cannot be predicted from
their predecessors. In most practical situations, distributional
properties can be calculated over a ‘window’ of samples and
used to make a prediction about future events. For example, if
the mean and sd of the first 2500 points is calculated, this
information can be used to predict the probability of future
point values and test these predictions. Such a prediction
would be: “Assuming this sample of 2500 points is sufficient
to estimate themean and sd of the underlying noise processes,
the next 2500 points are expected to have a similar mean and
sd.” Using the examples in Fig. 1, this prediction holds for
panels 1a and 1d but not for panel 1c. Using a window of 2500
samples identifies there is something ‘non random’ about
point ordering in panel 1c. Whilst the 2500 sample window did
not pick up the structure in panel 1d, many other window
sizes would, e.g. 250 observations per window.
Lag plots are another visualisation tool commonly used in
the characterisation phase of SPC to assist in finding cyclical
structure in thedata (such as that highlighted by thewindowing
examples). They can be used to systematically exploremultiple
‘data windows’. Fig. 2a shows an example lag plot. The concept
is very simple; ordered points are plotted against each other
with a time ‘lag’ i.e. if the chosen time lag is 1 then observation 1
is plotted against observation 2, observation 2 against observation
3 and so on. In random data any given observation should not
be consistently related to other observations so no clear structure
should be visible in the lag plot.
Fig. 2a shows an example of a typical lag plot for random
data and corresponds to the data shown in Fig. 1a. Fig. 2b
corresponds to thepoint ordering in Fig. 1d. There is clear visible
structure (the lag plot for Fig. 1c is not shown but is essentially




Fig. 2 – Lagplots for exploring structure in ordered observationdata. Visible structure in theplots suggests ‘non random’ components
to the observed variation.a) Lag plot for data shown in Fig. 1a. b) Lag plot for data shown in Fig. 1d. c) The observations in Fig. 1awith
added sinusoidal offsets. d) Lag plot for data shown in panel c.
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between the three cases is as obvious in the control chart views
as the lag plot views. Fig. 2c and d show a more meaningful
example. The distribution of points shown in Fig. 2cwas created
by adding sinusoidal variation to the points in Fig. 1a. The
points do not have the clear structural elements of panels 1c
and 1d. Fig. 2d shows the corresponding lag plot for the data
shown in Fig. 2c. There is now a clear structure in the lag
plot showing an underlying cyclical nature to the points.
It is advisable to explore a range of different lags when
characterising a system to detect cyclical behaviour with varying
cycle times. Results which do not resemble Fig. 2a are cause for
concern. In this example, although the points shown in Fig. 2c do
not have the same distributional properties as those shown in
Fig. 1, they do have the samemean and variance.
The ‘windowing’ of samples introduced in the previous
section shows what may be part of a practical solution i.e. it
shifts the question from ‘is this data subject to only random
variation?’ to ‘have the noise properties changed?’ Given
the assumption that the window of points is representative,
predictions can be made about how likely any given deviationfrom the mean is within a window i.e. assuming a normal
distribution, it is expected around 5 in 100 points will be 2 sd or
more from themean. If variance in theprocess starts to increase,
more points than expected will be beyond these limits. The
samewill result if themean starts to shift; sensitivity to this can
be increased by considering the deviation direction i.e. if a lot
more points cross +2 sd than expected.
A probability can therefore be assigned to each point
subsequently measured and the first stage of an SPC based QC
procedure implemented. QC limits can be set according to
local circumstances. For instance, it may be that allowing
itemswith ‘badmeasures’ to proceed to later processes is very
costly. Given that staff is happy to investigate events that
are relatively unlikely, a rule could be to investigate every
event which exceeds 2 sd from the mean. This introduces the
concept of a ‘run length’; the average of how many measures
are investigated as a proportion of thosemade. In this case 5 in
every 100 (i.e. 1 in every 20 measures) are predicted to trigger
investigation, giving an average run length of 20. Note that if
the distributional assumptions are correct and the process is
‘in control’ all of the 5 per 100 measures beyond the limits are
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variation. This is the ‘false positive’ price paid to enable detection
of change in the process if it occurs. This sort of compromise is
well accepted. p < 0.05 is often used as a threshold for signifi-
cance of an experimental difference. Simplistically, its meaning
translates to ‘I am happy that, given certain distributional
assumptions, I would only expect to see a difference in means
as big or bigger than the one observed (occurring by chance
variation alone) once in every 20 repeats of this experiment.’
Experiment design always involves cost and benefit thinking
(e.g. increasing the number of samples per experimental group
will have an implied cost but it will also improve confidence in
the results). A similar thought process is required in SPC where
the implications of a rule need to be considered. For example, if
investigating a rule failure involves repeating a measurement,
and this is cheap and easy to do, then it would make sense to
proceed. However, if repeat measurements are very costly (or
even impossible) it makes sense to attempt to reduce the false
positive rate. A practical approach to achieving this is to consider
‘chains of events’, i.e. the likelihood of observing consecutive
extreme measurements. This approach can produce rules more
capable of discriminating between ‘non random’ behaviour and
false positives from chance variation. ‘Chains of events’ allow
probabilities to be combined, producing fewer false positive
results whilst retaining operational flexibility. For example, if
a single point has a probability of 0.05 of exceeding 2 sd then
the probability of consecutively observing two such points
is 0.05 × 0.05 = 0.0025 (one in every 400 pairs of points). The
combination is far less likely to occur by chance than each
individual event.
The control chart is a powerful tool when used by an
experienced operator — humans have a particular natural
aptitude for seeing patterns in data. Whilst the experienced
practitioner is critical in the QC process, objective rules are
required to ensure consistency and transferability between
personnel thereby providing the capability to detect problems
as rapidly as possible. The control chart display, in combi-
nation with a skilled operator, would be sufficient to detect
issues in the example observations shown in Fig. 1. However,
whilst visually detecting and reporting obvious structure in
the data displayed in panels 1c and 1d is trivial, can rules be
derived which can do this objectively?
As an illustration, let us assume that 5000 measurements
have beenmade, obtaining the result shown in Fig. 1a. Themean
and sd limits shown are derived from these values. Although
this is a synthetic data set, it is clear within 10 observations that
both panels 1c and 1dhavemanymore pointswhich exceed the
2 sd limits thanwould be expected from the initial distributional
assessment, panel 1a. A ‘number of events beyond threshold’
rule would pick these up very quickly.
Setting control limits transforms a continuous output metric
into a dichotomous system; it is either within the control limits
(considered ‘in control’) or outside them (potentially ‘out of
control’). This gives four possibilities;• rule reported out of control and process actually out of
control (true positive or TP);
• rule reported out of control but process actually in control
(false positive or FP);• rule reported in control and process actually in control
(true negative or TN), and;
• rule reported in control but process was actually out of
control (false negative or FN).
Rules may also be linked, to improve sensitivity to changes
in process state. For example, a measurement falling outside
the upper limit of 3 sd may trigger an ‘alert state’ rule which
counts how many of the subsequent 10 measurements are
outside the 2 sd thresholds. This information can be used to
assess whether the initial event was a chance occurrence, or
an indication of the process entering an out of control state.
Generally, widening the thresholds will generate fewer FPs at
the cost of increased risk of FNs and conversely narrowing the
thresholds reduces FN risk at the cost of more FPs. Improving
the process can also reduce the total number of false results
which is one of the reasons why continuous process improve-
ment is a major objective of SPC.
There are two possible explanations for an observation
falling outside of a defined limit (for repeats of the same input);
1) it is a chance extreme point, or 2) somethingwithin the ‘black
box’ has changed. Since all measurements have a level of
uncertainty it is usual to consider ‘out of control’ events as
triggering a process or alert state. It may or may not lead to
a ‘stop the line’ (i.e. stop all measurements and investigate)
or ‘reject observation’ outcome depending on the situation.
A balance between quality and real-world constraints such as
time, cost and impact on downstream processes should be
achieved. It is important to consider each case and create an
objective set of rules, triggered by fixed criteria. At a minimum,
investigation of an ‘out of control event’ must end with a
documented decision about the response made to the event,
who decided this and why. QC management requires observa-
tion of the number of FPs versusTPs over time for any given rule
set, assessment of the process quality benefits realised versus
the time spent dealing with false alerts andmodification of the
rule set according to this information.
The control chart and rule combination is very flexible,
intuitive and powerful.Westgard et al. [5] provide farmore detail
on the rules used in clinical chemistry laboratories andhow they
can be linked together to achieve quality objectives. Section
1.3.3.15. of NIST/SEMATECH e-Handbook of Statistical Methods
[6] reviews system characterisation using these tools whilst
chapter 6 of the same on-line resource provides amore in-depth
overview of some of the concepts discussed in this text.
Many proteomics discovery research studies are es-
sentially complex data ‘manufacturing’ pipelines yet it is
common to wait until the ‘whole car has been assembled’
before any of the measurements are questioned. The
application of SPC to multiple analyte measurement sys-
tems is not entirely obvious, as simple application of one
rule per analyte will soon result in every sample failing; if a
‘within 2 sd of themean’ rule was used, on average 1 analysis
in every 20 would be expected to fail by chance variation
alone. Therefore every sample would have a high probabil-
ity of failing one of the many QC rules as soon as more than
20 analytes were being measured simultaneously. The rest
of this paper and a companion paper [7] show practical ways
to implement SPC work-flows whilst avoiding this ‘multiple’
testing problem.
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Many proteomics data sets with ‘repeated measures of the
same sample’ already exist; every data set created using the
2D DIGE strategy [8] has a repeated standard in every gel for
example. The DIGE design actually produces three data sets;
a set of repeated standards (single stain), a set of samples
(single stain) and the DIGE combined and corrected data set
itself. DIGE is designed to compensate for per analyte shifts in
the measurement platform and as such can mask them. It
is important to know about these shifts from the point of view
of process characterisation and SPC, even if downstream
compensation is in place. The built-in standard provides us
with a wealth of information to explore the properties of the
measurement system with respect to potential noise factors.
This paper uses the ‘three data set’ strategy to explore practical
work-flows enabling statistical process control in research
proteomics.
The 2D DIGE data set used is that described in Jackson et al.
[9], which is freely available online. The general details of the
sample processing protocol are not repeated here but some
factors specifically relevant or unique to this paper are described
(more processing details are available in the Supplementary
data).
Originally, the study was designed to assess population
variance amongst healthy subjects. Briefly, 31 male and 30
female participants were sampled to produce the data set. Two
blood samples were taken per individual with a 7-day interval
between sampling (except for one male individual who only
provided a single sample). This produced a set of 2 samples for
60 donors resulting in 120 dual channel gels (totalling 121 with
the one visit sample included). There was a known production
issue with the first 2D gel batch causing the gels to overrun
(i.e. relative to the rest of the gel set some of the spot features
have run off the bottom edge of these gels). These six additional
gels were omitted from the original analysis performed by [9] but
included in the on-line data to allow others to explore QC issues.
These six additional sample re-runs bring the total up to 127 gels
producing 254 image files (the failing samples were re-run once
all the samples had been processed and added to the data set).
The gels are a two stain DIGE experiment designwhere the same
pooled internal standard sample was run using Cy3 on every gel
along with one of the samples in the Cy5 channel (see Fig. 1 in
the Supplementary data for a schematic overview of the sample
set).
Detailed meta data was recorded for the whole data set and
was also provided on-line. The keymeta data factors (using the
nomenclature defined in the original publication) we consider
in this paper are:
• 2D Gel Batch — the gel production batch (1 to 14, batch 1 has
known issues and batch 14 is a re-run of those samples)
• IEF Batch for IPG strip — which IPG strips were run together
(1 to 12)
• Labelling Batch—which samples were labelled together (1 to 7)
• Visit — which visit the sample was from (2 or 3)
• Position in Tank—which location the gel was in the tank (1 to 5)
• Scanner — two Typhoon 9400 scanners were used across the
whole gel set (1 or 2)• PMT Voltage for Cy3 — what was the voltage set for the
scanner for the Cy3 images (note the scan images were
intentionally optimised once per gel batch by pre-scanning
one of the images and optimising the PMT voltage to get
serotransferrin on the gel to be in a set range)
• PMT Voltage for Cy5 — what was the voltage set for the
scanner for the Cy5 images (optimised in same manner as
Cy3 images)
The analysis in this paper uses the same image alignment
as the original paper but has different spot feature data.
The aligned images were loaded into Progenesis SameSpots
version 4.5 [10] and features were detected automatically.
This produced 1004 spot features. The feature outlines were
applied to the images and ‘raw volumes’ calculated (by simply
summing together the calibrated pixel values within the spot
feature boundaries). No background correction, normalisation
or further processing is included in these values.
The style of work-flow outlined supports the post analysis
of an already completed data set and also an ongoing study
where any new samples are aligned to the chosen reference
space and the pattern is simply applied and metrics derived.
This in no way restricts the downstream analysis where
different feature detection could be used.
All subsequent analysis presented in this paper was
performed in R [11] (for base functionality and plotting) with
custom scripting and supporting packages rms [12] (for varclus),
VSN [13,14] (for vsn2), and car [15] (for dataEllipse).
This paper explores these raw values under four distinct
normalisation/data transformation strategies:
1. log2 raw volumes — the raw values under a log base 2
transformation
2. Variance Stabilisation Normalisation (VSN) of the standards —
VSN transform of the standards based on raw volumes
using a reference group including standards in 2D gel
batches 2–6. These samples are effectively mapped to a log2
space.
3. Variance Stabilisation Normalisation (VSN) of the samples —
VSN transform of the samples based on raw volumes using
a reference group including standards in 2D gel batches 2–6.
These samples are effectively mapped to a log2 space.
4. Difference of the VSN samples with respect to the VSN values
of their standard channels (i.e. per gel VSN(Cy5)−VSN(Cy3)) —
values corrected to their standards based on the previous
two VSN calculation criteria.
The normalisation strategy employed is the vsn2 command
from the VSN R package [13]. This version has the capability
of allowing a reference set to be specified that defines the
reference normalisation space, this feature makes it easy for
us to add new observations as they become available.
For the standards set, the normalisation referencewas based
on ‘2D Gel Batch’ 2 through to 6. The same subset was used
for the samples but based purely on sample related measures
i.e. standards are referenced to standards and samples are
referenced to samples. The VSN algorithmproduces normalised
values in a spaceanalogous to log2 transformof the rawdata and
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log2 raw data sets.
The final data set achieves ‘standardisation of samples’
simply by subtracting the aforementioned standard data from
the samples data on a gel by gel basis. No attempt was made
to shift the mean of the result so these samples will not
necessarily have an effective mean ratio of 1. The ‘difference
VSN’ samples are equivalent to a ratio space representation of
feature expression.3. Results
3.1. Control charts for proteomics data
As discussed above, the first task to be carried out is system
characterisation. log2 transformed raw feature volume data
from all of the standards was used to highlight additional
considerations and visualisations before systematically con-
sidering multiple transforms and different data types.
Consideration of themeta data in Section 2 indicatesmany
factors which may be expected to affect the bulk of the
features simultaneously (e.g. the PMT voltage setting on the
scanner). This suggests that an obvious first metric for
exploratory system characterisation is some form of global
measure. Fig. 6 from [9] shows the design plot based on a
subset of the meta data factors and how they group a global
measure (the median values of all features on a gel).
In general, there is no requirement to use a global metric. A
subset of features could be used and can provide more
sensitivity to specific issues [7]. There is also no limit on the
number of metrics or rules used except that the portfolio of
rules should be considered as a whole in cost benefit terms.
Themetric presented in all of the graphs and analysis in this
section is themedian value of all of the 1004 features from a gel
image under the specified transformation or normalisation
scheme. All the results have used batches 2–6 as a reference set
for calculation of the mean and control limits and for the
purposes of normalisation when applicable.
The various control chart versions in this section add more
andmore information to the plots to assist in the exploration of
‘assignable cause’. In general this involves layering information
frommeta data factors onto the chart.
Fig. 3 shows a control chart based on taking the chosen
metric for each of the standard gels. This chart is slightly
different to those presented in the Introduction. The observa-
tions are in ‘2D Gel Batch’ order and the batch information is
now shown on the plot. Visually, there is already a suggestion
that assignable cause variation is present, with some correla-
tion to ‘2D Gel Batch’.
Fig. 4 shows the distributional information for the data
shown in Fig. 3. Visually there may be some suggestion of non-
normality but the distributionwould not really suggest an issue
with particular batches.
Given that visually several batches appear to be subject to
some form of assignable cause, we can explore defining limits
that would objectively report this. In the Introduction, the
creation of statistical limits and the possibilities of windowing
data was discussed, but details of how the mean and limits
should be calculated was not. Shewart [16] formulated theinitial work in this area. The Shewart version of the control
chart usually calculates limits from batched observations and
utilises running limits. Subsequently, Levey and Jennings [17]
developed a version that is more convenient for routine use
in clinical chemistry laboratories. Their approach utilises a
number of reference samples from which the limits are
derived. They suggest that the reference set should remain
valid for a certain time period or reagent batch after which the
system should be re-assessed and potentially re-calibrated.
There is an obvious trade off between generating stable and
meaningful limits and the number of standards you need to
produce them.
There are no clear specifications on how many samples
should be used to derive the population metrics. Fig. 5 shows
how the estimate of the mean and sd cumulatively develops
across the data set as increasing numbers of observations are
included. Despite the variation present across the whole
graph, the estimates are relatively stable after 20–40 observa-
tions even with the inclusion of the scanner setting induced
shifts in batches 8, 10 and 12. Over the full set it appears that
using smaller numbers of observations to assess themean and
control limits has a tendency to underestimate the variance,
resulting in narrower limits and potentially more false
positive ‘out of control’ events. Consider Fig. 6, this uses the
standard gels from 2D gel batches 2 through 6, which results
in tighter limits and the ‘rejection’ of three observations
which were not rejected when the limits were set using all
observations. Also note in Fig. 6 that stricter 2 sd limits (which
would flag up all points in the yellow or red areas) would have
at least one ‘rule fail’ for all of the batches that look to have
shifts visually.
The first question that occurs once the ‘black box’ is
reported as being ‘out of control’ is; ‘Is there an assignable
cause?’. This leads to consideration of batching and meta
data. As previously mentioned, the [9] study recorded many
meta data factors whilst processing experimental samples.
These range across reagent batch, the scanner used and its
settings, and which gels were run in the same tank and their
position in the tank. Generally experimenters have to
consider the factors that they believe could systematically
influence their results and at least record the details. Batch
meta information can be layered on top of the control chart to
allow for a visual inspection of potential factors affecting
process performance. Fig. 7 shows such a display.
The original experiment was not designed to allow full
separation of the meta factors and as such they are not all
independent. This can be exploredmore formally using variable
clustering. Fig. 8 shows the output from the varclus command
from the rms package [12] in R [11]. In this analysis the meta
factors are themselves clustered together (irrespective of the
measured feature data in the gels). This showswhichmeta data
factors are related. In this gel set, ‘Labelling batch’, ‘2D Gel
Batch’ and ‘IEF batch for IPG strips’ are closely related so it is
unlikely that one of these factors can be isolated as a lone cause
of variation.
The final tool used is the lag plot which allows us to assess
cyclical behaviour within sample windows, which was also
discussed in the Introduction. Fig. 9 shows a version where
additional information is provided. The observations have
been coloured by ‘2D Gel Batch’ (and also numbered) which
Fig. 3 – An example control chart for the median of standard feature values per gel. The blue points and lines show sequential
observations of the chosen ‘metric’. The left hand y-axis shows the values in the original metric space and the right hand axis
shows themetric points mapped to a standardised space based on an estimate of themean and standard deviation of the chosen
reference set (all observations in this plot). Observations in the reference set are coloured grey in the bar at the bottom of the plot.
The green background rectangle highlights the area that pointswithin 2 sd of themean reside. The yellow rectangles showwhere
points between2 and 3 sd of themean reside and the red areas showwhere points between 3 and 4 sd from themeanwould reside.
The vertical lines denote boundaries between subsequent batches, in this case, the 2D gel batch. The number of the batch is given
in the corresponding rectangles at the bottomof the plot. The red lines and squares at the right of the plot showthemeanand±1 sd
points of all of the observations regardless of what the reference set is.
11J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1gives a visual indication as to whether outlier behaviour is
batch related. A simple set of data bounds have been added
which depictwheremost of the data is expected to reside, given
estimates based on the data itself and normality assumptions.
The inner ellipse is expected to contain 50% of the data and the
outer ellipse 95% (using the dataEllipse function from the car [15]42.0 42.5 43.0 43.5 44.0
Fig. 4 – Distributional overview for median of all features
applied to image log2 raw volumes.package). For a normally distributed randomprocess, a uniform
cloud of points is expected to develop. In Fig. 9 we can see that
this appears to be the case for most of the batches, but batches
8, 10 and 12 deviate from this distribution.
The visualisations and metrics discussed do not report on
the absolute performance of the system. Being ‘in control’ does
notmean a systemhas high performance; it simplymeans that
it is operating in the manner we would expect it to given some
window of past performance. It is obvious that a ‘noisy system’
will have wider absolute limits than a ‘low noise’ system.
Our focus in this paper is on initially characterising the state of
the system, providing a route to improvement and creating
rules that objectively warn when system performance may be
unexpectedly changing. The practitioners may well wish to
benchmark their system against other such systems as part of
the characterisation process but this is beyond the scope of this
paper.
The tools and visualisations described can now be used
to explore properties of the data set and give an indication
of the sorts of QC issues that SPC could objectively report on.
3.2. Standards log2 transformed raw volume
Fig. 7 shows the data for all of the log2 raw volume results from
the standards. As noted earlier the chart is unremarkable
except for apparent excursions in batches 8, 10 and 12, most
likely linked to scanner settings. It is interesting that batch 1
Fig. 5 – The green line shows how the estimate of themean alters asmore observations are included. It shows a cumulative estimate
i.e. the line value at observation 20 includes all observations up to 20. The orange polygon shows the same estimate for how the sd
develops as more points are used in its calculation.
12 J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1(with the known running error that caused around one fifth of
the gel features to be missing) looks very well behaved under
this scheme and metric. This is not entirely unreasonable
given the way the gel scans were optimised for scanning and
the use of the median of a large number of features.Fig. 6 – This plot shows using a reduced reference set. 2D gel batc
and sd that areused in the control limits. Observations that are colou
limits (mean ± 3 sd in this example). The observations used in the
bottom of the plot.Fig. 9 shows the lag plot for the same data. Asmentioned in
Section 3.1 the points appear to be clustered reasonably
tightly with notable excursions for batches 8, 10 and 12.
Fig. 10 shows a design plot similar to the one presented
in the Jackson et al. [9] paper. The design plot is anotherhes 2 through to 6 are used to calculate the estimates formean
red red insteadof bluedenotepoints outside thedefined control
reference set can be seen coloured grey in the rectangles at the
Fig. 7 – Control chart with ‘meta ribbons’ added. The meta ribbons show how various meta batches correspond with observation
values. Each strip is independent, so the colours used in ‘2DGel Batch’ ribbon are not related specifically to the colours used in say
‘IEF Batch for IPG strip’ ribbon. A different colour is used for each unique batch factor.
13J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1alternative visualisation of the data shown in the control
chart. Design plots were discussed in detail by Jackson et al.
[9]. Briefly, instead of focussing mainly on a single meta data
batch factor, the design plot lists a number of factors and
shows how the median of the observations included under
different batch schemes would plot on the control chart. The
chart has been extended to show the same statistical limits
as the control charts. We can see from this data presentation
that the most outlying 2D gel batches are 12, 10, 8 and 13
which supports the conclusions of the previous two figures.
There is a suggestion that IEF batch for IPG strip 10 is
an outlier but as we noted under the variable clustering
analysis (Fig. 8) that the meta data does not offer us the
capability to really separate out the factorswith any confidence.

























































































Fig. 8 – Variable clustering for ‘all standards’ meta data.voltage setting has quite an impact on the metric being used—
as we may expect given this is raw scan data.
3.3. Standards under Variance Stabilisation Normalisation
The original study utilised a scanning rule that sought to
standardise batch scanning by optimising the value of a few
features on the gel (serotransferrin). Normalisation schemes,
such as VSN, can utilise information from many features and
through this can provide more reliable estimates of the
behaviour of the whole population that are more robust to
outliers. They also add assumptions about the underlying
distributions of the data. It can be useful to explore the impact
of these assumptions by adding analysis steps in stages.
The previous section showed the raw data, now we explore
how further processing and assumptions can change our view
of the data. Fig. 11 shows the control chart for the standards
under the VSN scheme. It is clear that the normalisation scheme
has successfully compensated for the differences in scanner
settingwith batches 8, 10 and 12 now appearing to fit in with the
rest of the batches. Batch 1 (with gel over-run issues) is now
clearly showing as an outlier.
Fig. 12 tells a similar story with a tighter cluster of batches
showing batch 1 as a clear outlier. There is also some suggestion
that batch 14 may have an undiagnosed issue.
Fig. 13 clearly shows how the VSN transformation has
reduced the impact of the scanner settings with the ANOVA
for PMT Cy3 now reporting no significant difference between
the settings based on using the batch medians as a metric.
Again, batch 1 is a clear outlier under 2D gel batch grouping and
there is a suggestion of problemswith batch 14. Asmeta factors
for the IEF and labelling batches are known to correlate with the
2D gel batch they are not considered any further here.
Fig. 9 – Each observation is plottedwith respect to its immediate predecessor. In a randomprocesswewould expect this to produce a
reasonably tightly clustered ellipse of points. Systematic trends developingwill tend tomove the centre of the clusters of points along
the y = x line. The points have been coloured tomatch the 2D gel batch colours used in themeta data ribbon on the control charts and
thenumbers are the batch numbers. The red ellipses showdata bounds that denote areas inwhich 50%and 95% of the data points
would be expected to lie assuming a 2D normal distribution.We can see that the points frombatch 12, when taken as a group, are














































































































































































































Fig. 10 –Median of groupmedians under variousmeta data batching schemes. Ifwe take the leftmost line first, this corresponds to
the data that we have plotted in the previous control charts. Each point on the vertical line shows themedian of the ‘metric’ points
within that batch. The numbers in brackets are the number of the observations for the given batch. Each of the subsequent vertical
lines shows the results for batching the observations by alternativemeta data criteria. The p values supplied with the vertical line
labels are the results of anANOVAof themetric observation values groupedby the correspondingmetadata and they are suggestive
of factors that may be significant in producing shifts in the data.
14 J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1
Fig. 11 – Control chart for median of all features applied to image set ‘all standards’, fixed reference VSN single stain.
15J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1The raw and the normalised views of the data are relatively
simple to produce andwewould recommend the use ofmultiple
views and data processing schemes in parallel when exploring
the system characteristics.
3.4. Samples under Variance Stabilisation Normalisation
Fig. 14 shows the control chart for the samples under the
VSN scheme. The results are essentially the same as for
the standards with batch 1 clearly an outlier. This is a veryFig. 12 – Lag plot for median of all features applied to imagencouraging result as it suggests that, for proteomics data,
the statistical process control technique not only works for
repeats of the same sample but can also function when
biological variation is included not only in the data itself but
also in the reference set. This may not be the case for all data
sets so it is recommended that this finding should be confirmed
for any given experiment design.
It is not entirely surprising that a global metric of samples
behaves in a similar manner as a global metric of standards.






















































































































































































































Fig. 13 – Design plot for median of all features applied to image set ‘all standards’, fixed reference VSN single stain.
16 J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1analytes are affected under the experimental conditions’ for
some time; it is assumed by almost all data normalisation
schemes. The presentations in this section suggest that the same
assumption can be used to consider some sample features as
‘built in standards’ for QC purposes. The fact that the DIGE gel
pair is highly correlated could have contributed to the similarity
of the result but both analyses were conducted independently.Fig. 14 – Control chart for median of all features applied to iAt least, thisdemonstrates that thebiological variationwithin the
sample set does not prevent technical issue rules being derived.
Fig. 15 shows the corresponding lag plot. It, too, is similar
to the standards version (Fig. 9) but with less suggestion of an
issue with batch 14. The design plot for the samples (Fig. 16)
is also very similar to the standards version and again fails to
show an issue for batch 14.mage set ‘all samples’, fixed reference VSN single stain.
Fig. 15 – Lag plot for median of all features applied to image set ‘all samples’, fixed reference VSN single stain.
17J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 13.5. Samples under Variance Stabilisation Normalisation
difference to standards
Fig. 17 shows the control chart for the VSN difference case.
Batch 1 is not reported as having any issues. This is expected
as the over-run affects both stains within the gel equally and
hence is masked. In this case, the batch quality issue was
easily identified by the experimenters but in other cases
the images are altered in a more subtle way which may still
matter, for example a technical issue with albumin overloads
that causes material to be deposited as streaks in an area of
the gel containing other features. In this case the problem
may not be detected so easily because the issue equally
affects both sample and standard images and can mask the
real expression values without anything unusual appearing in
the differential data. Jackson and Bramwell [7] explore these
issues in more detail.
It is important that an experimenter is informed when
such masking may be occurring. The QC procedure can be
adapted to utilise not only the whole image but subsets of
features that report on the QC of different sections of the data.
It may be that the investigation of an outlier highlights such a
localised issue and a rule is created to report specifically on
this in the future (see [7] for specific examples).
There are indications of an issue with batch 14 with the
meta ribbon suggesting that there may be a problem with
the 2D gel batch, IEF batch or labelling batch. Batch 14 was the
re-run batch of batch 1. This is a post analysis so there is little
more that can be done other than be cautious about results
from that batch. Additional analyses to localise the origin of
a noted difference are also possible by comparing differential
results versus other batches. If this analysis had been per-
formed as part of the original experiment it would have been
possible to explore the issue more fully and potentially re-runthe samples. Batch 14 did not stand out as an outlier batch in
the original Jackson et al. analysis. This may be a result of the
differing feature sets employed as 4534 features were used in
the original paper compared to 1004 in this analysis.
Figs. 18 and 19 show the lag and design plots for the VSN
difference data. These support the conclusions drawn from
the control chart although it is interesting to note that in the
design plot the scanner setting value spread seems to have
a larger relative impact than was observed in the VSN single
stain experiments. It may be that future experiments should
explore whether the scanner setting optimisation strategy
needs review. Simply locking the scanner settings to a pre-set
value may also cause issues, as this leads to some gels losing
dynamic range whilst others saturate out certain feature sets.
The control chart approach gives a metric to explore this, but
the impact of such procedural changes must be considered
for the entire process ‘end-to-end’. It is important to take a
pragmatic approachandaimto identify themetricswhich report
on key factors, i.e. those directly impacting upon the desired
quality of the experiment. Becoming unduly concerned with
optimising all aspects of a process can actually be counter-
productive, as this consumes valuable time and resources yet
can potentially yield negligible benefits.4. Discussion
Implementation of even a simple statistical process control
work-flow can provide useful and timely information on
potential technical issues occurring within complex proteomic
analysis processes. Control charts are easy to create and
interpret, and allow for objective rules and procedures to be
implemented to detect and deal with issues that may impact






































































































































































































































Fig. 16 – Design plot for median of all features applied to image set ‘all samples’, fixed reference VSN single stain.
18 J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1objective— if anobservation is outside of pre-determined limits
a procedure is triggered, which will lead to one of a defined set
of outcomes.
Once process metrics have been defined the resourcing
overhead of running the procedures is generally much lower
than one may initially assume and can easily be scripted
using freely available software tools to run, in many cases,
automatically.Fig. 17 – Control chart for median of all features applied toAs discussed above, process characterisation is key to
successfully implementing SPC. For this reason, we recom-
mend extensive routine meta data collection during analyses,
at least until the main factors impacting upon the perfor-
mance of a process are regarded as being well-understood.
We also recommend that samples are analysed blind with
regard to their experimental grouping and that all statistical
QC processes are completed before this blind is broken andimage set ‘all samples’, fixed ref VSN(Cy5)–VSN(Cy3).
Fig. 18 – Lag plot for median of all features applied to image set ‘all samples’, fixed ref VSN(Cy5)–VSN(Cy3).
19J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1data analysis intended to address experimental hypotheses
commences. This ensures that QC decisions on inclusion
and rejection of data from the final analysis can be made
objectively and consistently across the entire experimental
data set, without being influenced by whether data corre-











































































































































Fig. 19 – Design plot for median of all features applied toProvided that QC metrics are stable, it does not matter
if the final data analysis strategy is different to the QC
strategy, so long as the process implemented suits a particular
researcher's requirements. It should not matter that the QC
procedure does not use all the data used in the final analysis or


















































































image set ‘all samples’, fixed ref VSN(Cy5)–VSN(Cy3).
20 J O U R N A L O F P R O T E O M I C S 9 5 ( 2 0 1 3 ) 3 – 2 1although itmay be beneficial to implement QC atmultiple stages
in the processing and analysis pathway as we have shown.
This article was only intended to serve as an introduction to
statistical process control and demonstrate the potential of the
technique. The analyses discussed outlined procedures capable
of; objectively rejecting a known ‘bad’ gel batch without visual
inspection of the actual gels themselves, identifying scanner
setting changes and highlighting a potential issue for further
investigation in the DIGE data. As every DIGE experiment
generates three data sets that can be analysed in this manner,
a large amount of data is already in existence which can be used
to explore rules and assess performance inmany research areas.
More complex and advanced QC schemes could be defined,
which would still map back to the simplicity of the control
chart methodology but operate not only on single derived
global measures, but also on all or just particularly relevant
subsets of data. This strategy has the potential for better
assessment of locally occurring effects [7].
One of the key concepts of SPC is ‘the process of continuous
improvement’. In practice, thismeansmaking pragmatic choices
and operating with a good compromise between overall quality
assessment and resource overheads, whilst maintaining vigi-
lance for unexpected events. If a serious quality issue occurs it
should be investigated, especially if existing procedures failed
to identify it. This then gives an opportunity for procedures to
be improved upon, with the result over time being an overall
improvement in process quality and hence also in the quality of
the results it generates.
This article has shown that the SPC approach provides useful
and timely information for 2D gel electrophoresis data. Is it really
applicable and necessary for the more automated and cutting edge MS
based work-flows used by most proteomics researchers today? History
seems to suggest that the answer is clearly that attention
to quality and reproducibility is crucial for translation from
research to practical applications. The research proteomics
community would consider clinical chemistry lab analyte
measurement as a ‘gold standard’ to aspire to, but the level
of performance routinely available today is the result of
many years of effort. Tonks [18], in his 1963 paper, reports,
when 170 Canadian clinical chemistry labs analysed pre-
prepared samples for, now routine, analytes such as total
protein, total cholesterol and glucose, that ‘Over 40% of the
3762 values reported fell outside of the allowable limits of
errors’. SPC has played an important role in achieving the
improvements leading to the systems and processes that
clinicians now rely on. Today's fully automated, custom
designed, clinical chemistry systems are still frequently used
with SPC oversight and are never assumed to just consis-
tently provide accurate results ‘because this is the latest and
best hardware available’.
In terms of ease of implementation, recent ‘IDfree’ MS
approaches, such as those detailed in the QuaMeter suite of
tools [19], are ideal candidates for tracking via control charts and
are amenable to essentially automated application and reporting.
The ‘IDfree’ approaches also allow the ‘data manufacturing’
pipeline to be split down, removing the additional assumptions
and complexity of the downstream analysis. Less of the ‘car’
needs to be built before you find the defective ‘gasket’.
The recent ABRF PRG 2012: Quality Control LC–MS/MS
study [20] discusses the need for improved QC oversight inLC–MS/MS analysis and highlights how broadly applicable and
robust the QuaMeter metrics are across a range of proteomics
analysis work-flows. The early reports [21] show metric data
plotted in a sequential sample format analogous to the control
chart and many exhibit clear structure. The 2013 presentation
from that study [22] demonstrates some potentially surprising
outcomes. Results were highly variable month-to-month
with respect to both the number of peptides and even the
parent protein species detected. This being despite contributors
analysing the same, relatively simple sample mixture, on the
same hardware platforms, using the same standardised work-
flowandunder the full knowledge that theseanalyseswerepart
of a longitudinal QC study. That is not to say this would be the
case with an experimental work-flow but it is certainly a factor
worthy of further exploration and a clear target to assist in
guiding process improvement.5. Conclusions
Statistical process control is a very versatile QC technique that
utilises simple but powerful charts and rules. It has been
proven time and again to have high value and applicability,
including routine use in clinical diagnostic laboratories for
the assurance of quantitative and qualitative assays. This
article has demonstrated that through the use of some simple
techniques and the monitoring of some simple derived metrics
we are able to reveal significant facts about a data set. These
same metrics could be measured on-line to provide early
warning of developing issues with little ongoing effort. Imple-
mentation of similar techniques in other industrial sectors has
clearly shown that their regular use leads to increasing process
and output quality.
The process of defining ‘quality’ in any particular setting
and the consideration of factors which may impact upon this
is valuable in its own right. Spending time as a research team
simply trying to carry this out and considering rules which
objectively report upon ‘quality’ can improve experimental
designs and procedures, even if formal control rules are not
implemented. But, it must always be remembered that ‘One
gets what onemeasures’ — if you do not measure quality, then
you will not get it.AcknowledgementsThe authorwould like to acknowledgeDr. BenChaffey, Dr. David
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